Clinical Trials Browser

Peritoneal Neoplasms × Bevacizumab × Gastrointestinal × Clear all

NCT02399410 2024-01-30

Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis

Phase 2 Completed

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms